company logo

Executive Director, GPS, Inflammation & AutoImmunity at Incyte in Wilmington, DE

Save

compensation:

$80K — $100K *

specialty:

Life Sciences

experience:

Not Specified

Job Description

See More

Valid through: 11/2/2020

About Incyte

Incyte, Corp is an American pharmaceutical company based in Alapocas, Delaware. Incyte has one drug which has been approved by the U.S. Food and Drug Administration (FDA) and has been prescribed to several thousands of patients in the United States, Jakafi. The company was founded in Palo Alto, California in 1991 and went public in 1993. As of 2014 the company was developing an oral JAK1 and JAK2 inhibitor drug for rheumatoid arthritis in partnership with Eli Lilly called baricitinib. As of August 2016[update] 31 clinical trials had been registered for baricitinib of which 24 had completed, and 4 of 6 phase 3 trials had completed. As of 2016 epacadostat, an Indoleamine 2,3-dioxygenase (IDO1) inhibitor, is in development for various cancers. The ECHO-202 study (NCT02178722) is evaluating epacadostat in combination with Keytruda® (pembrolizumab)*, Merck’s anti-PD-1 therapy.
stats icon
Total Jobs:
39
stats icon
Total Experts:
3
stats icon
Average Pay:
$144,062
stats icon
Total value of jobs:
$9,220,000
stats icon
% Masters:
41%
Learn More About Incyte view all icon
* Ladders Estimates

More Jobs at Incyte

Director, HEOR

$200K — $250K

19 days ago

Similar Jobs

More Pharmaceuticals & Biotech Jobs

Principal Electrical Engineer (Medical Device)

$150K — $160K

Confidential Company

Cambridge, MA 02138

2 days ago

Toxicology Manager

Confidential Company

Greensboro, NC 27401

3 days ago

Find similar executive director, gps, inflammation & autoimmunity jobs: